Answer in brief
CVE-2026-100560 records a High severity (CVSS 7.7) vulnerability in OpenClaw before 2026.8.1 Reusable Exec Approvals Authorization Bypass. The current sources do not mark it as known exploited. The current feed maps OpenClaw/OpenClaw (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
CVSS is 7.7. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps OpenClaw/OpenClaw (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| OpenClaw/OpenClawgeneric | >=0 <2026.8.1 | 2026.8.1 |
Published upstream
Sep 26, 2026
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Sep 26, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Sep 26, 2026
OpenClaw versions before 2026.8.1 contain an authorization bypass vulnerability where Allow Always approvals for exact commands persist as path-only grants on macOS and Linux. Attackers can reuse the same executable with different arguments to execute commands without triggering new approval prompts, potentially accessing files or internal services.
Quoted source text, attributed separately from HOL analysis.